A recent study has demonstrated that Angelica gigas acts to improve inflammation by inhibiting mitogen-activated protein kinase (MAPKs) and nuclear factor-κB pathway (NF-κB) when it is applied to animal models of atopic dermatitis [8]. The gene discussed is WNK2; the disease is atopic eczema.